Graf James A 4
4 · NKGen Biotech, Inc. · Filed Dec 10, 2024
Insider Transaction Report
Form 4
Graf James A
Chief Executive Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2024-12-06+500,000→ 500,000 totalExercise: $0.44Exp: 2034-12-06→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]On December 6, 2024, the Reporting Person was granted 500,000 options pursuant to the Company's 2023 Equity Incentive Plan, with 25% vesting immediately as of the grant date, and the remaining options vesting in 36 equal installments on the sixth of each month, beginning January 6, 2025, and ending December 6, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.